Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease

被引：0
|
作者：
Volkers, A. [1 ]
Straatmijer, T. [1 ]
Duijvestein, M. [2 ]
Sales, A. [1 ]
Levran, A. [1 ]
van Schaik, F. [3 ]
Jeroen, M. [4 ]
Gecse, K. [1 ]
Ponsioen, C. [1 ]
Grootjans, J. [1 ]
Hanzel, J. [1 ]
Tack, G. [5 ]
Jansen, J. [6 ]
Hoentjen, F. [7 ]
de Boer, N. [1 ]
van der Marel, S. [8 ]
Dijkstra, G. [9 ]
Oldenburg, B. [3 ]
Lowenberg, M. [1 ]
van der Meulen, A. [4 ]
D'Haens, G. [1 ]
机构：
[1] Amsterdam UMC, Locat AMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
[3] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[4] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[5] Med Ctr Leeuwarden, Dept Gastroenterol & Hepatol, Leeuwarden, Netherlands
[6] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[7] Univ Alberta, Dept Med, Div Gastroenterol, Edmonton, AB, Canada
[8] Haaglanden Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[9] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP63
引用
收藏
页码：I108 / I109
页数：3
相关论文
共 50 条
  • [31] Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease
    Costa, Carmen Amor
    Ferrer, Cristina Suarez
    Ramirez, Laura Garcia
    Martin-Arranz, Eduardo
    Cordon, Joaquin Poza
    Garcia, Jose Luis Rueda
    Azofra, Maria Sanchez
    Diaz, Irene Gonzalez
    Roig, Clara Amiama
    Martin-Arranz, Maria Dolores
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2025, 48 (03):
  • [32] TRANSITIONING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (TRAVELESS)
    Ventress, Esther
    Rahmany, Sohail
    Young, David
    Bettey, Marion
    Harris, Clare
    Moyses, Helen
    Smith, Trevor
    Felwick, Richard
    Gwiggner, Markus
    Cummings, Fraser
    GUT, 2021, 70 : A83 - A84
  • [33] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Haddley, K.
    DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
  • [34] Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases
    Bacsur, Peter
    Resal, Tamas
    Sarlos, Patricia
    Ilias, Akos
    Sumegi, Liza Dalma
    Kata, Diana
    David, Anett
    Farkas, Bernadett
    Ivany, Emese
    Balint, Anita
    Bosze, Zsofia
    Fabian, Anna
    Bor, Renata
    Szepes, Zoltan
    Afif, Waqqas
    Bessissow, Talat
    Farkas, Klaudia
    Lakatos, Peter L.
    Molnar, Tamas
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [35] Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease
    Bye, W. A.
    Jairath, V.
    Travis, S. P. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (01) : 3 - 15
  • [36] Safety and effectiveness of vedolizumab for the treatment of paediatric patients with Inflammatory Bowel Diseases
    Fabiszewska, S.
    Derda, E.
    Szymanska, E.
    Osiecki, M.
    Kierkus, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I498 - I498
  • [37] Safety and effectiveness of vedolizumab for the treatment of paediatric patients with Inflammatory Bowel Diseases
    Fabiszewska, S.
    Derda, E.
    Szymanska, E.
    Osiecki, M.
    Kierkus, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I498 - I498
  • [38] Needle or Drip?-Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases
    Outtier, An
    Ferrante, Marc
    DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (01) : 17 - 18
  • [39] Inflammatory Bowel Disease Patients' Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience
    Remy, Clotilde
    Caron, Benedicte
    Gouynou, Celia
    Haghnejad, Vincent
    Jeanbert, Elodie
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [40] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Mosli, Mahmoud
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward Vincent, Jr.
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
12345